Drug · DIN 02230784
TAZORAC
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 26, 2021; first marketed April 10, 1997.
- Drug Identification Number (DIN)
- 02230784
- Company (DIN owner)
- Allergan IncMarkham, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Topical
- Therapeutic class (ATC)
- Tazarotene D05AX05
- Class
- Human
- Record last updated
- June 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TAZAROTENE | 0.05 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 25, 1997: NOC 4122New Drug Submission (NDS)
Other DINs named TAZORAC
- DIN 02230785 · Cancelled Post Market
- DIN 02243894 · Cancelled Post Market
- DIN 02243895 · Cancelled Post Market